Retrospective cohort study identifies risk factors and develops a prediction model for refracture in osteoporotic patients, indicating which require closer monitoring.
To investigate the risk factors for new vertebral compression fractures (NVCFs) after percutaneous kyphoplasty (PKP) for osteoporotic vertebral compression fractures (OVCFs) and to construct a postoperative risk stratification nomogram for predicting refracture probability and identifying high-risk patients who require intensive postoperative monitoring and aggressive preventive interventions. This retrospective cohort study enrolled 257 patients with single-segment OVCFs treated at Hainan General Hospital from January 2021 to December 2023. Participants were stratified into refracture (n = 56) and non-refracture (n = 201) groups based on new vertebral fracture occurrence within 1-year post-PKP. Data were randomly partitioned into training (n = 180) and validation (n = 77) sets at a 7:3 ratio. Independent risk factors were identified through univariate screening followed by multivariate logistic regression. A refracture risk nomogram was constructed using significant multivariate predictors, with comprehensive validation of predictive utility through tripartite assessment: receiver operating characteristic curve analysis, calibration curves, and decision curve analysis (DCA). Univariate analysis revealed significant between-group differences in sex, bone mineral density (BMD), vertebral height recovery rate, fracture severity, intradiscal cement leakage, anti-osteoporosis treatment, early postoperative mobilization, and history of postoperative falls (all P < 0.05). Multivariate analysis identified moderate fractures [OR = 7.08, 95%CI (1.39-54.00), P = 0.029], severe fractures [OR = 8.60, 95%CI (2.03–60.20), P = 0.009], intradiscal cement leakage [OR = 10.40, 95%CI (2.55–51.30), P = 0.002], and postoperative falls [OR = 4.99, 95%CI (1.75–15.30), P = 0.003] as independent risk factors positively associated with refracture. Conversely, higher BMD [OR = 0.61, 95%CI (0.40–0.91), P = 0.016], anti-osteoporosis treatment [OR = 0.24, 95%CI (0.08–0.63), P = 0.005], and early mobilization [OR = 0.28, 95%CI (0.09–0.77), P = 0.017] demonstrated protective effects. The nomogram maintained robust discrimination across cohorts: training set AUC = 0.892 (95%CI:0.832–0.952) with 78.60% sensitivity and 89.90% specificity at 0.355 cut-off; testing set AUC = 0.836 (95%CI:0.691–0.982) with 78.60% sensitivity and 85.70% specificity at 0.269 cut-off. Calibration curves demonstrated good agreement between predicted and observed outcomes. Decision curve analysis (DCA) demonstrated clinical utility with positive net benefits at 0%-76% (training) and 0%-82% (testing) risk thresholds. Low BMD, moderate-severe fracture severity, bone cement intradiscal leakage, inadequate anti-osteoporosis treatment, delayed postoperative mobilization, and falls are predominant risk factors for NVCFs after PKP. A validated nomogram prediction model was developed based on these six established risk factors. Clinical trial number: not applicable.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: